TREMELIMUMAB Pharmacologic Class Indexing
- Class set ID
- 2db67acd-b907-413a-9d97-fcf633f7b1f3
- Version
- 1
- Effective date
- 20231129
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use IMJUDO safely and effectively. See full prescribing information for IMJUDO. IMJUDO ® (tremelimumab-actl) injection, for intravenous use Initial U.S. Approval: 2022 | AstraZeneca Pharmaceuticals LP | 20240724 | 14 |